| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Previous Article | Next Article ![]()
Departments of Molecular Microbiology, Pathology & Immunology, Medicine, and Anatomy and Neurobiology, Washington University School of Medicine, St. Louis, MO 63110
* To whom correspondence should be addressed. Email:
diamond{at}borcim.wustl.edu.
Recent studies have established a protective role for T cells during primary West Nile virus infection. Binding of CD40 by CD40 ligand (CD40L) on activated CD4+ T cells provides an important co-stimulatory signal for immunoglobulin class switching, antibody affinity maturation, and priming of CD8+ T cell responses. Herein, we examined the function of CD40-dependent interactions in limiting primary WNV infection. Compared to congenic wild type mice, CD40-/- mice uniformly succumbed to WNV infection. Although CD40-/- mice produced low levels of WNV-specific IgM and IgG, viral clearance from the spleen and serum was not altered and CD8+ T cell priming in peripheral lymphoid tissues was normal. Unexpectedly, CD8+ T cell trafficking to the CNS was markedly impaired in CD40-/- mice, and this correlated with elevated WNV titers in the CNS and death. In the brains of CD40-/- mice, T cells were retained in the perivascular space and did not migrate into the parenchyma, the predominant site of WNV infection. In contrast, in wild type mice, T cells trafficked to the site of infection in neurons. Beside its role in maturation of antibody responses, our experiments suggest a novel function of CD40-CD40L interactions: to facilitate T cell migration across the blood-brain barrier to control WNV infection.
Copyright (c) 2007, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.
CD40-CD40 Ligand Interactions Promote Trafficking of CD8+ T Cells into the Brain and Protection against West Nile Virus Encephalitis
![]()
Abstract
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|